Cargando…
Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356670/ https://www.ncbi.nlm.nih.gov/pubmed/35949405 http://dx.doi.org/10.1093/ofid/ofac378 |
Ejemplares similares
-
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
por: El Adam, Shiraz, et al.
Publicado: (2022) -
Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada
Publicado: (2023) -
Correction to: Single-Dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Alpha and Gamma Variants: A Test-Negative Design in Adults 70 Years and Older in British Columbia, Canada
Publicado: (2023) -
Outpatient antibiotic use in British Columbia, Canada: reviewing major trends since 2000
por: Saatchi, Ariana, et al.
Publicado: (2021) -
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)